I had the good fortune recently to attend a symposium to hear international experts João Goulão and Eric Costen from Portugal and Canada talking about the transformative reforms to drug laws in their respective countries. It was excellent to see how successful these have been, although Canada is admittedly only six months into its reform agenda. It was equally interesting to hear the concerns some people raised around drug law reform – concerns many New Zealanders and politicians have thought about.
Firstly, that legalising cannabis will make cannabis more available, particularly to vulnerable groups like young people. In reality, a liberalised regime where cannabis is easy to get hold of by all kinds of people, including vulnerable groups, is the position we are in now with prohibition and our current drug laws. The biggest myth of prohibition is that drugs are not available in our society – about 275 million people worldwide, roughly 5.6 per cent of the global population aged 15–64 years, used drugs at least once during 2016, according to the 2018 World Drug Report. A regulated cannabis regime, which is what is being proposed by reformers for New Zealand, would protect young people and other vulnerable groups by making cannabis harder for them to get hold of. The ‘product’ would also be quality controlled, standardised and have strength/dose information – something unavailable in the current illegal market. Drug law reformers are also concerned about the unregulated use of some drugs by vulnerable people and seek reform to protect those groups (as Canada has done). Cannabis law reform will not be a chaotic ‘free for all’. Continue reading Let’s be Pragmatic about Drugs